Two Biotechs That Will Shine Bright in 2018
Despite the quiet, there is market-making news for us this week, as the Food and Drug Administration announced a delay in processing an application for one of our triple-digit winners... Plus, we're taking a look forward to a calendar packed with profit-generating catalysts in the new year.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.